 As noted in the CY 2022 Physician Fee Schedule (PFS) final rule under the "Maintenance Process for MVPs" section (86 FR 65410), CMS is soliciting stakeholder recommendations for potential updates to the 7 established MVPs that were finalized for implementation beginning in the 2023 MIPS performance period/2025 MIPS payment year. On a rolling basis, CMS is accepting stakeholder requests for changes to the 7 established MVPs finalized in the Appendix 3: MVP Inventory of the CY 2022 PFS final rule (86 FR 65998) The 7 established MVPs include: - Advancing Rheumatology Patient Care
- Coordinating Stroke Care to Promote Prevention and Cultivate Positive Outcomes
- Advancing Care for Heart Disease
- Optimizing Chronic Disease Management
- Adopting Best Practices and Promoting Patient Safety within Emergency Medicine (finalized with modification)
- Improving Care for Lower Extremity Joint Repair (finalized with modification)
- Support of Positive Experiences with Anesthesia (finalized with modification)
CMS will determine if approved changes to finalized MVPs will be addressed through future notice and comment rulemaking; for example, suggesting the addition or removal of a quality measure or improvement activity. CMS is unable to communicate with a stakeholder about whether or not their recommendations are accepted ahead of rulemaking, and we would ultimately decide whether updates to the established MVPs should be made through future notice and comment rulemaking. In addition, as discussed in the CY 2022 PFS proposed rule (86 FR 39370), CMS may consult with the stakeholders who originally nominated the MVP about any publicly recommended changes to an established MVP. Please note that this solicitation doesn't extend to requests for changes to existing individual MIPS measures and improvement activities. Changes to individual MIPS measures and improvement activities are made through separate established processed under the traditional MIPS performance category policies and criteria for measures and activities. Those changes would be reflected within established MVPs. This ongoing maintenance process for finalized MVPs is also separate from the new MVP candidate solicitation process that was described in the CY 2021 PFS final rule (85 FR 84854 through 84856). Requests for changes to established MVPs should be submitted to PIMMSMVPSupport@gdit.com for CMS consideration. At a minimum, please provide the title of the established MVP and a succinct description of the proposed change(s) by performance category as organized in the table below. | MVP Title: | | Performance Category | Requested Change and Rationale | | Quality | | | Improvement Activities | | | Cost | | | Foundational Layer – Population Health | | | Foundational Layer – Promoting Interoperability | | Questions? Contact the Quality Payment Program at 1-866-288-8292 or by e-mail at: QPP@cms.hhs.gov, Monday-Friday 8 a.m.- 8 p.m. ET. To receive assistance more quickly, please consider calling during non-peak hours—before 10 a.m. and after 2 p.m. ET. Customers who are hearing impaired can dial 711 to be connected to a TRS Communications Assistant. Join the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) for a National Stakeholder Call providing updates on COVID-19, revisions to nursing home guidance, and best practices. Additionally, subject matter experts from CDC and CMS will address frequently asked questions. When: Wednesday, February 2, 2022, 3:00 PM-3:45 PM ET Where: Zoom link will be provided following registration. Panelists: - Lee Fleisher, CMS Chief Medical Officer and Director, Center for Clinical Standards and Quality (CMS)
- Jean Moody Williams, Deputy Director, Center for Clinical Standards and Quality (CMS)
- Kara Jacobs-Slifka, Long Term Care Lead, Prevention and Response Branch (CDC)
- Evan Shulman, Director, Division of Nursing Homes (CMS)
Who should attend: Long term care providers, facility staff and resident advocates. Registration is required: https://cms.zoomgov.com/webinar/register/WN_k97X8g_TRrqkn-w-FOhtCA | 
No comments:
Post a Comment